Skip to main content
Erschienen in: Obesity Surgery 5/2010

01.05.2010 | Clinical Research

Effects of Two Variants of Roux-en-Y Gastric Bypass on Metabolism Behaviour: Focus on Plasma Ghrelin Concentrations Over a 2-Year Follow-up

verfasst von: Noelia Pérez-Romero, Assumpta Serra, Maria Luisa Granada, Miquel Rull, Antonio Alastrué, Maruja Navarro-Díaz, Ramón Romero, Jaime Fernández-Llamazares

Erschienen in: Obesity Surgery | Ausgabe 5/2010

Einloggen, um Zugang zu erhalten

Abstract

Background

To study the effects of two variants of Roux-en-Y gastric bypass (RYGBP) on plasma ghrelin concentrations according to different exposure of gastric fundus to the nutrient pathway.

Methods

A prospective longitudinal 2-year follow-up study was conducted. Ninety-six morbidly obese (MO) patients (age range: 41.6 ± 9.6 years, body mass index: 53 ± 9.5 kg/m2) were assigned to two bariatric surgical (BS) procedures: one that preserves food contact with gastric fundus (ringed RYGBP, n = 50) and the other that avoids it (modified RYGBP, n = 46). Different anthropometric and biochemical parameters were studied, focusing on ghrelin concentrations at baseline and 6, 12, and 24 months post-BS.

Results

At 24 months post-BS, all metabolic parameters studied had improved in all patients compared with those at 1-year follow-up and baseline (p < 0.05). However, high-density lipoprotein cholesterol concentrations took 2 years to normalise in 80% of patients, interleukin-6 decreased significantly in relation to baseline only after 2 years from BS (p < 0.001), and tumour necrosis factor alpha concentrations did not significantly decrease during the 2 years of follow-up. Plasma ghrelin concentrations increased in both surgical groups compare to baseline during the first year (24.6% in modified RYGBP and 36.62% in ringed RYGBP) and remained stable at the second year of follow-up, with no statistical differences between groups.

Conclusions

In the second year of follow-up after BS, morbidity continued to improve in MO patients despite a lesser weight loss in relation to the first year. An increase in plasma ghrelin concentrations was found, regardless of nutrient contact with gastric fundus. Furthermore, changes in plasma ghrelin concentrations appeared to be independent of weight loss.
Literatur
1.
Zurück zum Zitat Mokdad AH, Ford ES, Bowman BA, et al. Prevalence of obesity, diabetes, and obesity-related health risks factors. JAMA. 2003;289:76–9.CrossRefPubMed Mokdad AH, Ford ES, Bowman BA, et al. Prevalence of obesity, diabetes, and obesity-related health risks factors. JAMA. 2003;289:76–9.CrossRefPubMed
4.
Zurück zum Zitat Gastrointestinal surgery for severe obesity. NIH consensus development conference, March 25–27, 1991. Nutrition 1996:12:397–404. Gastrointestinal surgery for severe obesity. NIH consensus development conference, March 25–27, 1991. Nutrition 1996:12:397–404.
5.
Zurück zum Zitat Stubbs RS, Wickremesekera SK. Insulin resistance in the severely obese and links with metabolic co-morbidities. Obes Surg. 2002;12:343–8.CrossRefPubMed Stubbs RS, Wickremesekera SK. Insulin resistance in the severely obese and links with metabolic co-morbidities. Obes Surg. 2002;12:343–8.CrossRefPubMed
6.
Zurück zum Zitat Pories WJ. Why does the gastric bypass control type 2 diabetes mellitus? Obes Surg. 1992;2:303–11.CrossRefPubMed Pories WJ. Why does the gastric bypass control type 2 diabetes mellitus? Obes Surg. 1992;2:303–11.CrossRefPubMed
7.
Zurück zum Zitat Schauer PR, Ikramuddin S, Gourash W. Outcomes after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Ann Surg. 2000;232:515–29.CrossRefPubMed Schauer PR, Ikramuddin S, Gourash W. Outcomes after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Ann Surg. 2000;232:515–29.CrossRefPubMed
9.
Zurück zum Zitat Kojima M, Hosoda H, Date Y, et al. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature. 1999;402:656–60.CrossRefPubMed Kojima M, Hosoda H, Date Y, et al. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature. 1999;402:656–60.CrossRefPubMed
10.
Zurück zum Zitat Gnanapavan S, Kola B, Bustin SA, et al. The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. J Clin Endocrinol Metab. 2002;87:2988–91.CrossRefPubMed Gnanapavan S, Kola B, Bustin SA, et al. The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. J Clin Endocrinol Metab. 2002;87:2988–91.CrossRefPubMed
11.
Zurück zum Zitat Papotti M, Ghè C, Cassoni P, et al. Growth hormone secretagogue binding sites in peripheral human tissues. J Clin Endocrinol Metab. 2000;85:3803–07.CrossRefPubMed Papotti M, Ghè C, Cassoni P, et al. Growth hormone secretagogue binding sites in peripheral human tissues. J Clin Endocrinol Metab. 2000;85:3803–07.CrossRefPubMed
12.
Zurück zum Zitat Wren AM, Seal LJ, Cohen MA, et al. Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab. 2001;86:599–02.CrossRef Wren AM, Seal LJ, Cohen MA, et al. Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab. 2001;86:599–02.CrossRef
13.
Zurück zum Zitat Berthoud HR. Vagal and hormonal gut-brain communication: from satiation to satisfaction. Neurogastroenterol Motil. 2008;20(Suppl 1):64–72.CrossRefPubMed Berthoud HR. Vagal and hormonal gut-brain communication: from satiation to satisfaction. Neurogastroenterol Motil. 2008;20(Suppl 1):64–72.CrossRefPubMed
14.
Zurück zum Zitat Date Y, Kojima M, Hosoda H, et al. Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology. 2000;141:4255–61.CrossRefPubMed Date Y, Kojima M, Hosoda H, et al. Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology. 2000;141:4255–61.CrossRefPubMed
15.
Zurück zum Zitat Arisayu H, Takaya K, Tagami T, et al. Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans. J Clin Endocrinol Metab. 2001;86:4753–8.CrossRef Arisayu H, Takaya K, Tagami T, et al. Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans. J Clin Endocrinol Metab. 2001;86:4753–8.CrossRef
16.
Zurück zum Zitat Wu JT, Kral JG. Ghrelin. Integrative neuroendocrine peptide in health and disease. Ann Surg. 2004;239(4):464–74.CrossRefPubMed Wu JT, Kral JG. Ghrelin. Integrative neuroendocrine peptide in health and disease. Ann Surg. 2004;239(4):464–74.CrossRefPubMed
17.
Zurück zum Zitat Faraj M, Lu HL, Cianflone K. Diabetes, lipids and adipocyte secretagogues. Biochem Cell Biol. 2004;82:170–9.CrossRefPubMed Faraj M, Lu HL, Cianflone K. Diabetes, lipids and adipocyte secretagogues. Biochem Cell Biol. 2004;82:170–9.CrossRefPubMed
18.
Zurück zum Zitat Vendrell J, Broch M, Vilarrasa N, et al. Resistin, adiponectin, ghrelin, leptin and proinflammatory cytokines: relationships in obesity. Obes Res. 2004;12:962–71.CrossRefPubMed Vendrell J, Broch M, Vilarrasa N, et al. Resistin, adiponectin, ghrelin, leptin and proinflammatory cytokines: relationships in obesity. Obes Res. 2004;12:962–71.CrossRefPubMed
19.
Zurück zum Zitat Ballantyne G, Gumbs A, Modlin I. Changes in insulin resistance following bariatric surgery and the asipoinsular axis: role of the adipocytokines, leptin, adiponectin and resistin. Obes Surg. 2005;15:692–9.CrossRefPubMed Ballantyne G, Gumbs A, Modlin I. Changes in insulin resistance following bariatric surgery and the asipoinsular axis: role of the adipocytokines, leptin, adiponectin and resistin. Obes Surg. 2005;15:692–9.CrossRefPubMed
20.
Zurück zum Zitat Lyon CJ, Law RE, Hsuch WA. Minireview: adiposity, inflammation, and atherogenesis. Endocrinology. 2003;144:195–200.CrossRef Lyon CJ, Law RE, Hsuch WA. Minireview: adiposity, inflammation, and atherogenesis. Endocrinology. 2003;144:195–200.CrossRef
21.
Zurück zum Zitat Serra A, Granada ML, Romero R, et al. The effect of bariatric surgery on adipocytokines, renal parameters and other cardiovascular risk factors in severe and very severe obesity: 1-year follow-up. Clinical Nutricion. 2006;25:400–8.CrossRef Serra A, Granada ML, Romero R, et al. The effect of bariatric surgery on adipocytokines, renal parameters and other cardiovascular risk factors in severe and very severe obesity: 1-year follow-up. Clinical Nutricion. 2006;25:400–8.CrossRef
22.
Zurück zum Zitat NIH Consensus Development Conference Draft Statement on Gastrointestinal Surgery for Sever Obesity. Obs Surg 1991; 1:257–65. NIH Consensus Development Conference Draft Statement on Gastrointestinal Surgery for Sever Obesity. Obs Surg 1991; 1:257–65.
23.
Zurück zum Zitat SEEDO. Consensus 2000 para la evaluación del sobrepeso y obesidad y el establecimiento de criterios de intervención terapéutica. Med Clin (Barc). 2000;115:587–97. SEEDO. Consensus 2000 para la evaluación del sobrepeso y obesidad y el establecimiento de criterios de intervención terapéutica. Med Clin (Barc). 2000;115:587–97.
24.
Zurück zum Zitat Fobi MA, Lee H, Holness R, et al. Gastric bypass operation for obesity. World J Surg. 1998;22:925–35.CrossRefPubMed Fobi MA, Lee H, Holness R, et al. Gastric bypass operation for obesity. World J Surg. 1998;22:925–35.CrossRefPubMed
25.
Zurück zum Zitat Salmon PA. Gastroplasty with distal gastric bypass: a new and more successful weight loss operation for the morbidly obese. Can J Surg. 1988;31:111–3.PubMed Salmon PA. Gastroplasty with distal gastric bypass: a new and more successful weight loss operation for the morbidly obese. Can J Surg. 1988;31:111–3.PubMed
26.
Zurück zum Zitat Mason EE. Vertical banded gastroplasty for obesity. Arch Surg. 1982;177:701–6. Mason EE. Vertical banded gastroplasty for obesity. Arch Surg. 1982;177:701–6.
27.
Zurück zum Zitat Serra A, Romero R, Lopez D, et al. Renal injury in the extremely obese patients with normal renal function. Kidney Int. 2008;73:947–55.CrossRefPubMed Serra A, Romero R, Lopez D, et al. Renal injury in the extremely obese patients with normal renal function. Kidney Int. 2008;73:947–55.CrossRefPubMed
28.
Zurück zum Zitat Friedewald WT, Levy RI. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of preparative ultracentrifuge. Clin Chem. 1972;18:499–502.PubMed Friedewald WT, Levy RI. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of preparative ultracentrifuge. Clin Chem. 1972;18:499–502.PubMed
29.
Zurück zum Zitat Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia. 1985;28:412–9.CrossRefPubMed Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia. 1985;28:412–9.CrossRefPubMed
30.
Zurück zum Zitat World Health Organization. Obesity: preventing and managing the global epidemic. In: Report on a WHO Consultation on Obesity: WHO/NUT/NCD/98.1. Geneva, Switzerland: World Health Organization; 1997. World Health Organization. Obesity: preventing and managing the global epidemic. In: Report on a WHO Consultation on Obesity: WHO/NUT/NCD/98.1. Geneva, Switzerland: World Health Organization; 1997.
31.
Zurück zum Zitat American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2004;27:S5–10.CrossRef American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2004;27:S5–10.CrossRef
32.
Zurück zum Zitat Shah M, Simha V, Garg A. Review: long-term impact of bariatric surgery on body weight, comorbidities, and nutritional status. J Clin Endocrinol Metab. 2006;91:4223–31.CrossRefPubMed Shah M, Simha V, Garg A. Review: long-term impact of bariatric surgery on body weight, comorbidities, and nutritional status. J Clin Endocrinol Metab. 2006;91:4223–31.CrossRefPubMed
33.
Zurück zum Zitat Pories WJ, Swanson MS, MacDonald KG, et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg. 1995;222:239–50.CrossRef Pories WJ, Swanson MS, MacDonald KG, et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg. 1995;222:239–50.CrossRef
34.
Zurück zum Zitat Scopinaro N, Adami GF, Marinari GM, et al. Biliopancreatic diversion. World J Surg. 1998;22:936–46.CrossRefPubMed Scopinaro N, Adami GF, Marinari GM, et al. Biliopancreatic diversion. World J Surg. 1998;22:936–46.CrossRefPubMed
35.
Zurück zum Zitat Smith S, Edwards CB, Goodman GN. Changes in diabetic management after Roux-en-Y gastric bypass. Obes Surg. 1996;6:345–8.CrossRefPubMed Smith S, Edwards CB, Goodman GN. Changes in diabetic management after Roux-en-Y gastric bypass. Obes Surg. 1996;6:345–8.CrossRefPubMed
36.
Zurück zum Zitat Cowan GS, Buffington CK. Significant changes in blood pressure, glucose, and lipids with gastric bypass surgery. World J Surg. 1998;22:987–92.CrossRefPubMed Cowan GS, Buffington CK. Significant changes in blood pressure, glucose, and lipids with gastric bypass surgery. World J Surg. 1998;22:987–92.CrossRefPubMed
37.
Zurück zum Zitat Pardina E, López-Tejero MD, Llamas R, et al. Ghrelin and apolipoprotein AIV levesl show opposite trends to leptin levels during weight loss in morbidly obese patients. Obes Surg 2009;19:1414–23. Pardina E, López-Tejero MD, Llamas R, et al. Ghrelin and apolipoprotein AIV levesl show opposite trends to leptin levels during weight loss in morbidly obese patients. Obes Surg 2009;19:1414–23.
38.
Zurück zum Zitat Vazquez LA, Pazos F, Berrazueta JR, et al. Effects of change in body weight and insulin resistance on inflammation and endothelial function in morbid obesity after bariatric surgery. J Clin Endocrinol Metab. 2005;90:316–22.CrossRefPubMed Vazquez LA, Pazos F, Berrazueta JR, et al. Effects of change in body weight and insulin resistance on inflammation and endothelial function in morbid obesity after bariatric surgery. J Clin Endocrinol Metab. 2005;90:316–22.CrossRefPubMed
39.
Zurück zum Zitat Faraj M, Havel PJ, Phélis S, et al. Plasma acylation-stimulating protein, adiponectin, leptin and ghrelin before and after weight loss induced by gastric bypass surgery in morbidly obese subjects. J Clin Endocrinol Metab. 2003;88:1594–02.CrossRef Faraj M, Havel PJ, Phélis S, et al. Plasma acylation-stimulating protein, adiponectin, leptin and ghrelin before and after weight loss induced by gastric bypass surgery in morbidly obese subjects. J Clin Endocrinol Metab. 2003;88:1594–02.CrossRef
40.
Zurück zum Zitat Holdstock C, Engström BE, Ohrvall M, et al. Ghrelin and adipose tissue regulatory peptides: effect of gastric bypass surgery in obese humans. J Clin Endocrinol Metab. 2003;88:3177–83.CrossRefPubMed Holdstock C, Engström BE, Ohrvall M, et al. Ghrelin and adipose tissue regulatory peptides: effect of gastric bypass surgery in obese humans. J Clin Endocrinol Metab. 2003;88:3177–83.CrossRefPubMed
41.
Zurück zum Zitat Hansen TK, Dall R, Hosoda H, et al. Weight loss increases circulating levels of ghrelin in human obesity. Clin Endocrinol. 2002;56:203–06.CrossRef Hansen TK, Dall R, Hosoda H, et al. Weight loss increases circulating levels of ghrelin in human obesity. Clin Endocrinol. 2002;56:203–06.CrossRef
42.
Zurück zum Zitat Shimizu Y, Noritoshi N, Isobe T, et al. Increased plasma ghrelin levels in lung cancer cachexia. Clin Cancer Res. 2003;9:774–78.PubMed Shimizu Y, Noritoshi N, Isobe T, et al. Increased plasma ghrelin levels in lung cancer cachexia. Clin Cancer Res. 2003;9:774–78.PubMed
43.
Zurück zum Zitat Nagaya N, Uematsu M, Kojima M, et al. Elevated circulating level of ghrelin in cachexia associated with chronic heart failure. Circulation. 2001;104:2034–8.CrossRefPubMed Nagaya N, Uematsu M, Kojima M, et al. Elevated circulating level of ghrelin in cachexia associated with chronic heart failure. Circulation. 2001;104:2034–8.CrossRefPubMed
44.
Zurück zum Zitat Tacke F, Brabant G, Kruck E, et al. Ghrelin in chronic liver disease. J hepatol. 2003;38:447–54.CrossRefPubMed Tacke F, Brabant G, Kruck E, et al. Ghrelin in chronic liver disease. J hepatol. 2003;38:447–54.CrossRefPubMed
45.
Zurück zum Zitat Otto B, Cuntz U, Fruehauf E, et al. Weight gain decreases elevated plasma ghrelin concentrations of patients with anorexia nervosa. Eur J Endocrinol. 2001;145:669–73.CrossRefPubMed Otto B, Cuntz U, Fruehauf E, et al. Weight gain decreases elevated plasma ghrelin concentrations of patients with anorexia nervosa. Eur J Endocrinol. 2001;145:669–73.CrossRefPubMed
46.
Zurück zum Zitat Adami GF, Cordera R, Andraghetti G, et al. Changes in serum ghrelin concentrations following biliopancreatic diversion for obesity. Obes Res. 2004;12:684–7.CrossRefPubMed Adami GF, Cordera R, Andraghetti G, et al. Changes in serum ghrelin concentrations following biliopancreatic diversion for obesity. Obes Res. 2004;12:684–7.CrossRefPubMed
47.
Zurück zum Zitat Nijhuis J, van Dielen FMH, Buurman WA, et al. Ghrelin, leptin and insulin levels after restrictive surgery: 2-year follow-up study. Obes Surg. 2004;14:783–7.CrossRefPubMed Nijhuis J, van Dielen FMH, Buurman WA, et al. Ghrelin, leptin and insulin levels after restrictive surgery: 2-year follow-up study. Obes Surg. 2004;14:783–7.CrossRefPubMed
48.
Zurück zum Zitat Schindler K, Prager G, Ballaban T, et al. Impact of laparoscopic adjustable gastric banding on plasma ghrelin, eating behaviour and body weight. Eur J Clin Invest. 2004;34:549–54.CrossRefPubMed Schindler K, Prager G, Ballaban T, et al. Impact of laparoscopic adjustable gastric banding on plasma ghrelin, eating behaviour and body weight. Eur J Clin Invest. 2004;34:549–54.CrossRefPubMed
49.
Zurück zum Zitat Stratis CH, Alexandrides TK, Vagenas K, et al. Ghrelin and peptide YY levels after variant of biliopancreatic diversion with Roux-en-Y gastric bypass versus after colectomy: a prospective comparative study. Obes Surg. 2006;16:752–8.CrossRefPubMed Stratis CH, Alexandrides TK, Vagenas K, et al. Ghrelin and peptide YY levels after variant of biliopancreatic diversion with Roux-en-Y gastric bypass versus after colectomy: a prospective comparative study. Obes Surg. 2006;16:752–8.CrossRefPubMed
50.
Zurück zum Zitat Garcia-Unzueta MT, Fernández-Santiago R, Domínguez-Díez A, et al. Fasting plasma ghrelin levels increase progressively after biliopancreatic diversion: one-year follow-up. Obes Surg. 2005;15:187–90.CrossRefPubMed Garcia-Unzueta MT, Fernández-Santiago R, Domínguez-Díez A, et al. Fasting plasma ghrelin levels increase progressively after biliopancreatic diversion: one-year follow-up. Obes Surg. 2005;15:187–90.CrossRefPubMed
51.
Zurück zum Zitat Geloneze B, Tambascia MA, Pilla VF, et al. Ghrelin: a gut-brain hormone: effect of gastric bypass surgery. Obes Surg. 2003;13:17–22.CrossRefPubMed Geloneze B, Tambascia MA, Pilla VF, et al. Ghrelin: a gut-brain hormone: effect of gastric bypass surgery. Obes Surg. 2003;13:17–22.CrossRefPubMed
52.
Zurück zum Zitat Frühbeck G, Díez-Caballero A, Gil MJ, et al. The decrease in plasma ghrelin concentrations following bariatric surgery depends on the functional integrity of the fundus. Obes Surg. 2004;14:606–12.CrossRefPubMed Frühbeck G, Díez-Caballero A, Gil MJ, et al. The decrease in plasma ghrelin concentrations following bariatric surgery depends on the functional integrity of the fundus. Obes Surg. 2004;14:606–12.CrossRefPubMed
53.
Zurück zum Zitat Kotidis EV, Koliakos G, Papavramidis TS, et al. The effect of biliopancreatic diversion with pylori-preserving sleeve gastrectomy and duodenal switch on fasting serum ghrelin, leptin and adiponectin levels: Is there a hormonal contribution to the weight-reducing effect of this procedure? Obes Surg. 2006;16:554–9.CrossRefPubMed Kotidis EV, Koliakos G, Papavramidis TS, et al. The effect of biliopancreatic diversion with pylori-preserving sleeve gastrectomy and duodenal switch on fasting serum ghrelin, leptin and adiponectin levels: Is there a hormonal contribution to the weight-reducing effect of this procedure? Obes Surg. 2006;16:554–9.CrossRefPubMed
54.
Zurück zum Zitat Adami GF, Cordera R, Marinari G, et al. Plasma ghrelin concentrations in the short-term following biliopancreatic diversion. Obes Surg. 2003;13:889–92.CrossRefPubMed Adami GF, Cordera R, Marinari G, et al. Plasma ghrelin concentrations in the short-term following biliopancreatic diversion. Obes Surg. 2003;13:889–92.CrossRefPubMed
55.
Zurück zum Zitat Stoeckli R, Chanda R, Langer I, et al. Changes of body weight and plasma ghrelin levels after gastric banding and gastric bypass. Obes Res. 2004;12:346–50.CrossRefPubMed Stoeckli R, Chanda R, Langer I, et al. Changes of body weight and plasma ghrelin levels after gastric banding and gastric bypass. Obes Res. 2004;12:346–50.CrossRefPubMed
56.
Zurück zum Zitat Cummings DE, Weigle DS, Frayo RS, et al. Plasma ghrelin levels alter diet-induced weight los sor gastric bypass surgery. N Engl J Med. 2002;346:1623–30.CrossRefPubMed Cummings DE, Weigle DS, Frayo RS, et al. Plasma ghrelin levels alter diet-induced weight los sor gastric bypass surgery. N Engl J Med. 2002;346:1623–30.CrossRefPubMed
57.
Zurück zum Zitat Karamanakos SN, Vagenas K, Kalfarentzos F, et al. Weight loss, appetite suppression, and changes in fasting and postprandial ghrelin and peptide-YY levels after Roux-en-Y gastric bypass and sleeve gastrectomy: a prospective, double blind study. Ann Surg. 2008;247(3):401–7.CrossRefPubMed Karamanakos SN, Vagenas K, Kalfarentzos F, et al. Weight loss, appetite suppression, and changes in fasting and postprandial ghrelin and peptide-YY levels after Roux-en-Y gastric bypass and sleeve gastrectomy: a prospective, double blind study. Ann Surg. 2008;247(3):401–7.CrossRefPubMed
58.
Zurück zum Zitat Ybarra J, Bobbioni-Harsch E, Chassot G, et al. Persistent correlation of ghrelin plasma levels with body mass index both in stable weight conditions and during gastric-bypass induced weight loss. Obes surg. 2009;19:327–31.CrossRefPubMed Ybarra J, Bobbioni-Harsch E, Chassot G, et al. Persistent correlation of ghrelin plasma levels with body mass index both in stable weight conditions and during gastric-bypass induced weight loss. Obes surg. 2009;19:327–31.CrossRefPubMed
59.
Zurück zum Zitat Garcia-fuentes E, Garrido-Sánchez L, Garcia-Almeida JM, et al. Different effect of laparoscopic Roux-en-Y gastric bypass and open biliopancreatic diversion of Scopinaro on serum PYY and ghrelin levels. Obes Surg. 2008;18:1424–9.CrossRefPubMed Garcia-fuentes E, Garrido-Sánchez L, Garcia-Almeida JM, et al. Different effect of laparoscopic Roux-en-Y gastric bypass and open biliopancreatic diversion of Scopinaro on serum PYY and ghrelin levels. Obes Surg. 2008;18:1424–9.CrossRefPubMed
Metadaten
Titel
Effects of Two Variants of Roux-en-Y Gastric Bypass on Metabolism Behaviour: Focus on Plasma Ghrelin Concentrations Over a 2-Year Follow-up
verfasst von
Noelia Pérez-Romero
Assumpta Serra
Maria Luisa Granada
Miquel Rull
Antonio Alastrué
Maruja Navarro-Díaz
Ramón Romero
Jaime Fernández-Llamazares
Publikationsdatum
01.05.2010
Verlag
Springer-Verlag
Erschienen in
Obesity Surgery / Ausgabe 5/2010
Print ISSN: 0960-8923
Elektronische ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-009-0035-0

Weitere Artikel der Ausgabe 5/2010

Obesity Surgery 5/2010 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.